被中饱私囊的脂肪——非酒精性脂肪性肝病

陈轶妍, 陆炎

doi:10.3969/j.issn.0253-9608.2019.06.004

自然杂志 >

2019 , Vol. 41 >Issue 6: 414 - 422

DOI: https://doi.org/10.3969/j.issn.0253-9608.2019.06.004

专题综述

被中饱私囊的脂肪——非酒精性脂肪性肝病

展开

复旦大学附属中山医院内分泌代谢病科，上海 200032

收稿日期: 2019-10-26

网络出版日期: 2019-12-20

收起

Fry in liver’s own grease: Non-alcoholic fatty liver disease

Expand

Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai 200032, China

Received date: 2019-10-26

Online published: 2019-12-20

Fold

摘要

随着生活方式的转变，非酒精性脂肪性肝病(non-alcoholic fatty liver disease, NAFLD)的患病率逐渐升高，已成为全世界最常见的肝病之一，但其危害程度没有受到足够的重视，目前也没有理想的治疗药物。文章简要阐述NAFLD的发病机制以及治疗的研究进展，以加深对其理解。

关键词： 非酒精性脂肪性肝病; 甘油三酯; 发病机制; 治疗

本文引用格式

陈轶妍, 陆炎 . 被中饱私囊的脂肪——非酒精性脂肪性肝病[J]. 自然杂志, 2019 , 41(6) : 414 -422 . DOI: 10.3969/j.issn.0253-9608.2019.06.004

Abstract

Due to lifestyle changes, the prevalence of non-alcoholic fatty liver disease (NAFLD) has increased and thus become one of the most common chronic liver diseases globally. However, adverse outcomes of NAFLD are undervalued and the first licensed drug for NAFLD has not yet been approved. Here, we summarize recent progress in the studies of the mechanism and new therapies of NAFLD, which may provide a better understanding of this disease.

Options

文章导航

模态框（Modal）标题

摘要

本文引用格式

Abstract